● Experience: Proven track record as a Chair, Non-Executive Director, or C-suite executive in high-growth tech or AI-driven companies. ● Commercialisation and investment: demonstrable experience of commercialisation and investment in high-growth organisations. Expertise in developing spinouts would be an advantage. ● Domain Knowledge: Strong understanding of AI-pharma, AI-clinical, or deep tech sectors, for example in molecular and genomics profiling, digital pathology and clinical AI, machine learning, multimodal AI. ● Compliance and Ethics: deep understanding of the compliance, legal, ethical, and regulatory issues around multimodal multi-omics datasets and AI in healthcare. ● Leadership: Demonstrated ability to lead diverse senior teams, manage complex stakeholder relationships, and navigate high-growth environments. ● Stakeholder engagement: access to an unrivalled network of potential partners and investors; commitment to collaborative working. ● Independence: No material existing contractual relationship with the four PharosAI CJV partners to ensure impartiality and objectivity. ● Communication: Excellent interpersonal and communication skills, with the ability to foster open dialogue, diplomacy, and consensus.

Overview of PharosAI

In the UK, someone is diagnosed with cancer every two minutes, and in 2021, 187k people living in the UK died from cancer. Novel, targeted, less toxic treatments, biomarkers for early detection, diagnostics, and clinical applications are urgently needed. Cancer AI Foundation Models, that have the capability to process multiple modalities of health data, including pathology, multi-omics, radiology images, and clinical text, are demonstrating exceptional performance in drug discovery and clinical tasks. Yet their development is hindered by data access, fragmentation, harmonisation, and governance issues. PharosAI aims to solve this complex challenge, democratising cancer AI and navigating the pathway to AI-powered cancer care. PharosAI is a contractual joint venture between two leading research-intensive universities, King’s College London and Queen Mary University of London and two innovative NHS Trusts, Guy’s and St Thomas’ NHS Foundation Trust and Barts Health Trust. PharosAI aims to accelerate AI-powered cancer care, driving breakthrough therapies, clinical applications, addressing cancer’s social determinants, lowering barriers to UK SMEs, catalysing innovation, and positioning the UK as a global leader in this dynamic ecosystem. PharosAI has been awarded £18.9M in Research Venture Catalyst funding from the Department for Science, Innovation, and Technology; and cash and in-kind contributions from partners across pharma, biotech, AI, and charities, bringing the total investment to £44M. PharosAI has exceptional stakeholder support from industry, policy-makers, and patients (PIVOT). PharosAI is led by an exceptional leadership team with expertise across the cancer R&D and commercialisation pathway. We intend to spin out PharosAI as an independent growth company within our three-year business plan. We have designed PharosAI to harness the enormous potential of research-active biobank data. PharosAI will create and curate unite unique, large-scale multimodal cancer datasets and combine them with AI models through a highly-secure, trusted, federated platform. Through these capabilities, PharosAI will offer an end-to-end cancer AI innovation and product development ecosystem for drug discovery and clinical applications as a service to researchers and developers in commercial and non-commercial research settings. PharosAI will accelerate cancer research, development, and innovation through AI, a market worth >$300bn globally. It will advance cancer discoveries, nurture high-growth companies, and stimulate economic growth. By fostering the next generation of innovators, researchers and clinicians, PharosAI will position the UK as a global cancer AI leader, ultimately benefitting patients worldwide.

To apply for this post you will need to register on the King’s College London job opportunities page and submit the application form, along with the following: • a concise statement setting out your reasons for applying for the post and highlighting the particular skills and experience which you feel you would bring to the role (two pages maximum) • a curriculum vitae

Equal opportunities

Equality, Diversity & Inclusion are central tenets of King’s Vision 2029 which sets out the roadmap for King’s ambition to provide an exceptional student experience and to be an employer of choice. Integral to this is ensuring equality of opportunity and outcome, recognising, celebrating and improving our diversity and inclusion. As a responsible employer we aim to provide and promote a positive working, learning, and social environment which is free from prejudice, discrimination and any forms of harassment, bullying or victimisation. Our commitment to inclusion means that King’s aims to create an environment where differences are not just respected, but also valued and celebrated. Everyone should be able to bring their whole self to King’s. All King’s students, staff and affiliates are responsible for meeting these commitments to value diversity and create an inclusive environment. King's will support and equip all members of its community to do this, embedding inclusion throughout the university’s policies, procedures, and practices.